Kidney Check: Diabetes, Blood Pressure & Kidney Health Checks & Care in Indigenous Communities.

Condition(s) studied

Investigational drug(s) / intervention(s)

Point-of-care screening: After consent is obtained, a registered nurse will administer a demographic questionnaire, collecting the participant's personal health number, age, gender, date of birth, and name of community. Physical data including height, weight, and blood pressure will also be collected. A blood sample and a urine sample will be taken, with point-of-care testing being performed during the screening appointment to allow for results of the testing to be received and discussed with each patient at the time of the appointment. After screening, to ensure a "closed loop" system of care, patients at the highest risk of kidney failure will be referred to a nephrologist, while those at lower risk will be referred to their primary care provider with specific treatment and re-testing recommendations.

Study summary

Faced with limited access to preventative health care services, Indigenous people living in rural and remote communities are at a higher risk of Chronic Kidney Disease (CKD) and kidney failure, when compared to the general population. The goal of this project is to perform point-of-care testing for CKD and its risk factors, including diabetes and high blood pressure, for individuals residing in rural and remote Indigenous communities across the Canadian provinces of Manitoba, British Columbia, Alberta, Saskatchewan, and Ontario. In addition to providing individuals with information about their risk of developing CKD, as well as providing tailored treatment plans, this study will help provide evidence to develop a permanent CKD surveillance system in all Indigenous communities across Canada, consequently decreasing the burden of CKD and kidney failure in these communities.

Eligibility

Primary outcome measure(s)

• Biomarkers of Kidney Function — 1 day (At time of screening)
  eGFR; Albuminuria; Urine ACR
• Diabetes — 1 day (At time of screening)
  Defined as a Hemoglobin A1c =\> 6.5%
• Elevated Blood Pressure — 1 day (At time of screening)
  Defined as a Systolic Blood Pressure \> 140 mmHg, or Diastolic Blood Pressure \> 90mmHg
• Kidney Failure Risk — 1 day (At time of screening)
  Measured using the Kidney Failure Risk Equation

Trial sites (3)

More University of Manitoba trials in Canada

Other trials for the same condition